Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2012

Sep 24, 2012

34117_dirs_2012-09-24_1006328b-b807-45d1-aa74-7a243eaee19c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-21

Reporting Person: HERMS HENRY P (Director, VP - Finance & CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-19 Employee Stock Option $0.235 A 300000 Acquired 2022-09-19 Common Stock (300000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the CopyTele, Inc. 2010 Share Incentive Plan.

F2: The option vests in 36 equal monthly installments beginning on 10/31/2012.